Overview

Joy Nemirow is a partner in the Intellectual Property Practice Group in the firm's Silicon Valley office.

Areas of Practice

Dr. Nemirow specializes in patent preparation, prosecution and strategy in the pharmaceutical, biotech, and chemical fields. She has extensive experience developing global patent portfolios, particularly covering small molecules, syntheses, polymorphs, formulations, and methods of use. Dr. Nemirow analyzes the validity of patents, freedom-to-operate, and inventorship and provides opinions and litigation strategies regarding validity and infringement in the ANDA context.

Dr. Nemirow also performs due diligence on patent portfolios for various types of transactions, including acquisitions, initial public offerings, and follow-on financing, with experience in representing the company and underwriter.

She received her Ph.D. in Chemistry from the University of Southern California. Her graduate research focused on the design and synthesis of novel bisphosphonates for their applications as fluorescent drug probes and as potential dental adhesives. As a graduate student, she was a member of the Interdisciplinary Program of Drug Discovery, where she gained vital exposure to the multidisciplinary fields of medicinal chemistry, pharmacology, and chemical biology. During law school, she served as the Chief Research Editor of the Loyola of Los Angeles Law Review.

Honors

Honors

Notable Practitioner, Managing Intellectual Property, 2022-2024

Ones to Watch — Intellectual Property Law, Best Lawyers, 2021-2025

Northern California Rising Star, Super Lawyers, 2017-2021

Insights

Articles

  • J. L. F. Bala, Note, Amicus Briefs: Sounding Off on Reforming Inequitable Conduct, 45 LOY. L.A. L. REV. 125 (2011)
  • C. E. McKenna, B. A. Kashemirov, & J. L. F. Bala. U.S. Patent No. 8,431,714
  • J. L. F. Bala, B. A. Kashemirov, & C. E. McKenna, Synthesis of a Novel Bisphosphonic Acid Alkene Monomer, 40 SYNTHETIC COMM. 3577 (2010)
  • C. E. McKenna, B. A. Kashemirov, K. M. Blazewska, I. Mallard-Favier, C. A. Stewart, J. Rojas, M. W. Lundy, F. H. Ebetino, R. A. Baron, J. E. Dunford, M. L. Kirsten, M. C. Seabra, J. L. Bala, M. S. Marma, M. J. Rogers, F. P. Coxon, Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid, 53 J. MEDICINAL CHEMISTRY 3454 (2010)
  • A. J. Roelofs, F. P. Coxon, F. H. Ebetino, M. W. Lundy, Z. J. Henneman, G. H. Nancollas, S. Sun, K. M. Blazewska, J. L. Bala, B. A. Kashemirov, A. B. Khalid, C. E. McKenna, M. J. Rogers, Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo. 25 J. BONE MINERAL RES. 606 (2010)
  • A. Boyde, M. W. Lundy, F. P. Coxon, C. E. McKenna, A. Roelofs, J. Bala, M. J. Rogers, K. Blazewska, R. G.G. Russelle, & F. H. Ebetino, The differential distribution in vivo of fluorescently-labeled bisphosphonate analogues with different mineral affinity to bone surfaces, 44 BONE S57 (2009)
  • B. A. Kashemirov, J. L. F. Bala, X. Chen, F. H. Ebetino, Z. Xia, R. G. G. Russell, F. P. Coxon, A. J. Roelofs, M. J. Rogers, & C. E. McKenna, Fluorescently Labeled Risedronate and Related Analogues: “Magic Linker” Synthesis, 19 BIOCONJUGATE CHEMISTRY 2308 (2008)
  • F. P. Coxon, J. L. Bala, B. A. Kashemirov, A. J. Roelofs, M. Lundy, X. Chen, Z. Xia, J. E. Dunford, R. G. Russell, M. J. Rogers, C. E. McKenna, & F. Ebetino, Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes, 82 CALCIFIED TISSUE INT’L S127 (2008)
  • A. J. Roelofs, F. P. Coxon, F. H. Ebetino, J. F. Bala, B. A. Kashemirov, C. E. McKenna, M. J. Rogers, Visualisation of cellular uptake and localisation of bisphosphonate in vivo using a fluorescent analogue of risedronate, 82 CALCIFIED TISSUE INT’L S59 (2008)
  • F. P. Coxon, J. L. Bala, B. A. Kashemirov, M. W. Lundy, X. L. Chen, Z. Xia, J. E. Dunford, G. G. Russell, A. J. Roelofs, M. J. Rogers, C. E. McKenna, & F. H. Ebetino, Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes, 42 BONE S36 (2008)
  • A. J. Roelofs, F. P. Coxon, F. H. Ebetino, J. F. Bala, B. A. Kashemirov, C. E. McKenna, & M. J. Rogers, Use of a fluorescent analogue of risedronate to study localisation and cellular uptake of bisphosphonates in vivo, 42 BONE (2008) S85
  • A. J. Roelofs, F. P. Coxon, M. W. Lundy, F. H. Ebetino, J. F. Bala, B. A. Kashemirov, C. E. McKenna, & M. J. Rogers, Studying Cellular Uptake and Distribution of Bisphosphonate in vivo Using Fluorescently-labelled Analogues of Risedronate, 23 J. BONE MINER. RES. S20 (2008)

Intellectual Property Law Blog Posts

  • "Federal Circuit Confirms Addition of Two Inventors of Groundbreaking Immunotherapies for Cancer," July 15, 2020

Life Sciences Law Blog Posts

Industries

Education

J.D., Loyola Law School, 2012

Ph.D., University of Southern California, 2009

B.S., Creighton University, 2004

Admissions

  • California
  • U.S. Patent and Trademark Office
Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.